Table 1 Description of the set of patients, containing the information of the total dose prescription (T.dose), and per fraction (F. dose), particle used (protons or carbon ions), existence of pre-treatment breathing signal (y- yes, n- no), number of treatment fractions with recorded monitoring (Fx.monit). The median vector field length for the most extreme breathing state to end-expiration (0%Ex) CT is for each patient 4DCT inside the ITV calculated (Max.MedianVFL). The adopted beam configuration (B.Config) follows the naming of the Fig. 1
From: Significance of intra-fractional motion for pancreatic patients treated with charged particles
Patient | T.Dose Gy (RBE) | Fx.dose Gy (RBE) | Particle | B.Config. | Pre-tt breath. signal | Fx.Monitor. | Max. MedianVFL (mm) |
|---|---|---|---|---|---|---|---|
H1 | 45 + 9 | 1.8 | p | B | Y | 2 | 8.7 |
H2 | 45 + 9 | 1.8 | p | B | Y | 1 | 6.9 |
H3 | 45 + 9 | 1.8 | p | C | Y | 1 | 4.6 |
H4 | 45 + 9 | 1.8 | p | B | Y | 3 | 3.1 |
H5 | 45 + 9 | 1.8 | p | B | Y | 4 | 3.3 |
H6 | 45 + 9 | 1.8 | p | B | N | 3 | 4.5 |
H7 | 54 | 2 | p | B | N | 1 | 4.6 |
H8 | 45 + 9 | 1.8 | p | B | Y | 1 | 4.1 |
H9 | 45 + 9 | 1.8 | p | B | Y | 1 | 4.7 |
H11 | 45 + 9 | 1.8 | p | B | Y | 3 | 5.0 |
H12 | 45 + 9 | 1.8 | p | A | Y | 6 | 12.7 |
H13 | 48 | 4 | 12C | B | Y | 2 | 5.0 |
H14 | 48 | 4 | 12C | B | Y | 1 | 3.1 |
H15 | 45 + 9 | 1.8 | p | B | Y | 1 | 2.2 |